| Followers | 24 |
| Posts | 1423 |
| Boards Moderated | 0 |
| Alias Born | 01/27/2021 |
Wednesday, April 17, 2024 10:34:49 AM
It looks like ChatGPT was hallucinating a little bit when it answered your second question. Yes, the trial-level judge who originally dismissed the case against Hikma can dismiss the lawsuit again, but only after both sides have the chance to gather and exchange evidence, including emails and correspondence that Amarin will hope contains a smoking gun or two that will further illustrate Hikma's bad intentions. At a later point prior to trial, Hikma will again move for dismissal of the lawsuit on the grounds that the judge can find as a matter of law that Amarin cannot satisfy the legal points necessary to take the case to a jury. And, at that stage, the rules of the game will not be as favorable to Amarin as they were at the current stage, when the trial judge was supposed to accept that everything in the lawsuit was true.
ChatGPT makes it sound like the judge can respond to the appeals reversal of his dismissal by merely writing the equivalent of a legal essay back to the appeals court to better explain why he threw out the case in a way that he thinks the appeals judges might accept.
With a reversal, three judges on the Federal Circuit (assuming its a unanimous ruling, which it certainly seemed it will be based on the tone of the arguments) will be telling the trial judge that he was wrong. The judge cannot then merely "choose to reaffirm its dismissal of the case" if he "believes that its original decision was correct." That's where ChatGPT was hallucinating.
Judges don't argue with each other that way. It's very much like the military. The lower court judge will be told politely by a superior (the Federal Circuit) that he is wrong. If he tried to protest and insist he was right, the higher court would take the gloves off and scold him like a small child. And he'd lose the respect of his fellow judges. I've been watching courts closely for nearly 50 years. This would never happen!
ChatGPT makes it sound like the judge can respond to the appeals reversal of his dismissal by merely writing the equivalent of a legal essay back to the appeals court to better explain why he threw out the case in a way that he thinks the appeals judges might accept.
With a reversal, three judges on the Federal Circuit (assuming its a unanimous ruling, which it certainly seemed it will be based on the tone of the arguments) will be telling the trial judge that he was wrong. The judge cannot then merely "choose to reaffirm its dismissal of the case" if he "believes that its original decision was correct." That's where ChatGPT was hallucinating.
Judges don't argue with each other that way. It's very much like the military. The lower court judge will be told politely by a superior (the Federal Circuit) that he is wrong. If he tried to protest and insist he was right, the higher court would take the gloves off and scold him like a small child. And he'd lose the respect of his fellow judges. I've been watching courts closely for nearly 50 years. This would never happen!
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
